|
1
|
Rashid MN, Fuentes F, Touchon RC and
Wehner PS: Obesity and the risk for cardiovascular disease. Prev
Cardiol. 6:42–47. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ajuwon KM and Spurlock ME: Adiponectin
inhibits LPS-induced NF-kappaB activation and IL-6 production and
increases PPARgamma2 expression in adipocytes. Am J Physiol Regul
Integr Comp Physiol. 288:R1220–R1225. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Anfossi G, Russo I, Doronzo G, Pomero A
and Trovati M: Adipocytokines in atherothrombosis: Focus on
platelets and vascular smooth muscle cells. Mediators Inflamm.
2010:1743412010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kawanami D, Maemura K, Takeda N, Harada T,
Nojiri T, Imai Y, Manabe I, Utsunomiya K and Nagai R: Direct
reciprocal effects of resistin and adiponectin on vascular
endothelial cells: A new insight into adipocytokine-endothelial
cell interactions. Biochem Biophys Res Commun. 314:415–419. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lau DC, Dhillon B, Yan H, Szmitko PE and
Verma S: Adipokines: Molecular links between obesity and
atheroslcerosis. Am J Physiol Heart Circ Physiol. 288:H2031–H2041.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Berg AH and Scherer PE: Adipose tissue,
inflammation and cardiovascular disease. Circ Res. 96:939–949.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Guerre-Millo M: Adipose tissue and
adipokines: For better or worse. Diabetes Metab. 30:13–19. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sethi JK and Vidal-Puig A: Visfatin: The
missing link between intra-abdominal obesity and diabetes? Trends
Mol Med. 11:344–347. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wu ZH and Zhao SP: Adipocyte: A potential
target for the treatment of atherosclerosis. Med Hypotheses.
67:82–86. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Blankenberg S, Barbaux S and Tiret L:
Adhesion molecules and atherosclerosis. Atherosclerosis.
170:191–203. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Libby P, Ridker PM and Maseri A:
Inflammation and atherosclerosis. Circulation. 105:1135–1143. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kougias P, Chai H, Lin PH, Yao Q, Lumsden
AB and Chen C: Effects of adipocyte-derived cytokines on
endothelial functions: Implication of vascular disease. J Surg Res.
126:121–129. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kralisch S, Sommer G, Stangl V, Köhler U,
Kratzsch J, Stepan H, Faber R, Schubert A, Lössner U, Vietzke A, et
al: Secretory products from human adipocytes impair endothelial
function via nuclear factor kappaB. Atherosclerosis. 196:523–531.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Cooke JP and Oka RK: Does leptin cause
vascular disease? Circulation. 106:1904–1905. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kougias P, Chai H, Lin PH, Lumsden AB, Yao
Q and Chen C: Adipocyte-derived cytokine resistin causes
endothelial dysfunction of porcine coronary arteries. J Vasc Surg.
41:691–698. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Samal B, Sun Y, Stearns G, Xie C, Suggs S
and McNiece I: Cloning and characterization of the cDNA encoding a
novel human pre-B-cell colony-enhancing factor. Mol Cell Biol.
14:1431–1437. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Sommer G, Garten A, Petzold S,
Beck-Sickinger AG, Blüher M, Stumvoll M and Fasshauer M:
Visfatin/PBEF/Nampt: Structure, regulation and potential function
of a novel adipokine. Clin Sci (Lond). 115:13–23. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Moschen AR, Kaser A, Enrich B, Mosheimer
B, Theurl M, Niederegger H and Tilg H: Visfatin, an adipocytokine
with proinflammatory and immunomodulating properties. J Immunol.
178:1748–1758. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lee WJ, Wu CS, Lin H, Lee IT, Wu CM, Tseng
JJ, Chou MM and Sheu WH: Visfatin-induced expression of
inflammatory mediators in human endothelial cells through the
NF-kappaB pathway. Int J Obes (Lond). 33:465–472. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Guzik TJ, Mangalat D and Korbut R:
Adipocytokines-novel link between inflammation and vascular
function? J Physiol Pharmacol. 57:505–528. 2006.PubMed/NCBI
|
|
21
|
Kim SR, Bae YH, Bae SK, Choi KS, Yoon KH,
Koo TH, Jang HO, Yun I, Kim KW, Kwon YG, et al: Visfatin enhances
ICAM-1 and VCAM-1 expression through ROS-dependent NF-kappaB
activation in endothelial cells. Biochim Biophys Acta.
1783:886–895. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Buldak RJ, Gowarzewski M, Buldak L,
Skonieczna M, Kukla M, Polaniak R and Zwirska-Korczala K: Viability
and oxidative response of human colorectal HCT-116 cancer cells
treated with visfatin/eNampt in vitro. J Physiol Pharmacol.
66:557–566. 2016.
|
|
23
|
Carmeliet P: Angiogenesis in health and
disease. Nat Med. 9:653–660. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kim SR, Bae SK, Choi KS, Park SY, Jun HO,
Lee JY, Jang HO, Yun I, Yoon KH, Kim YJ, et al: Visfatin promotes
angiogenesis by activation of extracellular signal-regulated kinase
1/2. Biochem Biophys Res Commun. 357:150–156. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Dahl TB, Yndestad A, Skjelland M, Øie E,
Dahl A, Michelsen A, Damås JK, Tunheim SH, Ueland T, Smith C, et
al: Increased expression of visfatin in macrophages of human
unstable carotid and coronary atherosclerosis: Possible role in
inflammation and plaque destabilization. Circulation. 115:972–980.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kotsopoulos J, Zhang S, Akbari M, Salmena
L, Llacuachaqui M, Zeligs M, Sun P and Narod SA: BRCA1 mRNA levels
following a 4–6-week intervention with oral 3,3′-diindolylmethane.
Br J Cancer. 111:1269–1274. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Simonini A, Moscucci M, Muller DW, Bates
ER, Pagani FD, Burdick MD and Strieter RM: IL-8 is an angiogenic
factor in human coronary atherectomy tissue. Circulation.
101:1519–1526. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yudkin JS, Kumari M, Humphries SE and
Mohamed-Ali V: Inflammation, obesity, stress and coronary heart
disease: Is interleukin-6 the link? Atherosclerosis. 148:209–214.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Takahashi M, Ikeda U, Masuyama J, Kitagawa
S, Kasahara T, Shimpo M, Kano S and Shimada K: Monocyte-endothelial
cell interaction induces expression of adhesion molecules on human
umbilical cord endothelial cells. Cardiovasc Res. 32:422–429. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Han SG, Newsome B and Hennig B: Titanium
dioxide nanoparticles increase inflammatory responses in vascular
endothelial cells. Toxicology. 306:1–8. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Adya R, Tan BK, Chen J and Randeva HS:
Nuclear factor-kappaB induction by visfatin in human vascular
endothelial cells: Its role in MMP-2/9 production and activation.
Diabetes Care. 31:758–760. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Adya R, Tan BK, Punn A, Chen J and Randeva
HS: Visfatin induces human endothelial VEGF and MMP-2/9 production
via MAPK and PI3K/Akt signalling pathways: Novel insights into
visfatin-induced angiogenesis. Cardiovasc Res. 78:356–365. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Collins T, Read MA, Neish AS, Whitley MZ,
Thanos D and Maniatis T: Transcriptional regulation of endothelial
cell adhesion molecules: NF-kappaB and cytokine-inducible
enhancers. FASEB J. 9:899–909. 1995.PubMed/NCBI
|
|
34
|
Said RS, El-Demerdash E, Nada AS and Kamal
MM: Resveratrol inhibits inflammatory signaling implicated in
ionizing radiation-induced premature ovarian failure through
antagonistic crosstalk between silencing information regulator 1
(SIRT1) and poly(ADP-ribose) polymerase 1 (PARP-1). Biochem
Pharmacol. 103:140–150. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Görlach A, Bertram K, Hudecova S and
Krizanova O: Calcium and ROS: A mutual interplay. Redox Biol.
6:260–271. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chaudhari N, Talwar P, Parimisetty A,
d'Hellencourt Lefebvre C and Ravanan P: A molecular web:
endoplasmic reticulum stress, inflammation, and oxidative stress.
Front Cell Neurosci. 8:2132014. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Shirai K: Obesity as the core of the
metabolic syndrome and the management of coronary heart disease.
Curr Med Res Opin. 20:295–304. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Van Gaal LF, Mertens IL and De Block CE:
Mechanisms linking obesity with cardiovascular disease. Nature.
444:875–880. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kim YR, Koh HJ, Kim JS, Yun JS, Jang K,
Lee JY, Jung JU and Yang CS: Peptide inhibition of p22phox and
Rubicon interaction as a therapeutic strategy for septic shock.
Biomaterials. 101:47–59. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ruiz-Ojeda FJ, Gomez-Llorente C, Aguilera
CM, Gil A and Rupérez AI: Impact of 3-amino-1,2,4-triazole
(3-AT)-derived increase in hydrogen peroxide levels on inflammation
and metabolism in human differentiated adipocytes. PLoS One.
11:e01525502016. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Satoh R, Kakugawa K, Yasuda T, Yoshida H,
Sibilia M, Katsura Y, Levi B, Abramson J, Koseki Y, Koseki H, et
al: PLoS Genet. 12:e10057762016. View Article : Google Scholar : PubMed/NCBI
|
